What is the Access Consortium? The consortium is a medium-sized coalition of regulatory authorities from Australia, Canada, Singapore, Switzerland and the UK that work together to promote greater regulatory collaboration and alignment of regulatory requirements.
Its purpose is to build synergies and maximize cooperation to ensure patients´ timely access to safe therapeutic products in member countries.
Find all related information about the Access Consortium here:
Flyer Acces Consortium Asphalion Regulatory Affairs
For further information, you can send us an email at: [email protected]
